Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- With Spring in Bloom, Here’s How to Navigate Allergies.
- What Caused COVID-19? What We Do (and Don’t) Know 5 Years Later.
- NJACTS Community Engagement Core COVID-19 Resources
- Missing the Old Days? Study Examines How Nostalgia Affects Us at Work.
- Rutgers Rises in National Top 100 Worldwide Patent Ranking.
Categories
- Community (2,212)
- Covid (985)
- CTO Events (6)
- News (2,821)
- Pilots (21)